Applied Health Economics and Health Policy

Article	Citations
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis	323
COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa	188
Willingness to Pay for a COVID-19 Vaccine	82
The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data	68
Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19	60
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic	47
Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19	32
Disease-Specific Out-of-Pocket Payments, Catastrophic Health Expenditure and Impoverishment Effects in India: An Analysis of National Health Survey Data	29
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany	27
The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations	27
Health Promoting Schools: An Update	25
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward	24
Health Financing in Sub-Saharan Africa: From Analytical Frameworks to Empirical Evaluation	23
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis	23
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	23
The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review	20
The Italian NHS: What Lessons to Draw from COVID-19?	19
COVID-19 Vaccine Demand and Financial Incentives	19
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options	19
Impact of a Global Pandemic on Health Technology Assessment	19
The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review	19
The Role of Mental Health on Workplace Productivity: A Critical Review of the Literature	18
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America	18
Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions	16
Costs of Illness of Spinal Muscular Atrophy: A Systematic Review	16

How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13	16
Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines	16
Population Norms for SF-6Dv2 and EQ-5D-5L in China	16
Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis	15
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	14
The Sandbox Approach and its Potential for Use in Health Technology Assessment: A Literature Review	14
Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives	14
Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance Scheme	13
Budget Impact of Microbial Cell-Free DNA Testing Using the Karius® Test as an Alternative to Invasive Procedures in Immunocompromised Patients with Suspected Invasive Fungal Infections	13
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	13
Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer	12
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom	12
Estimating Catastrophic Health Expenditures from Household Surveys: Evidence from Living Standard Measurement Surveys (LSMS)-Integrated Surveys on Agriculture (ISA) from Sub-Saharan Africa	12
‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions	12
Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations	11
EQ-5D-5L Health-State Values for the Mexican Population	11
The Health and Productivity Burden of Depression in South Korea	11
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30	11
Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries	11
Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?	11
Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review	11
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment	10
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy	10
Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment	10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	10
Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus	9
National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India	9
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models	9
Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?	8
The Impact of Financing Health Services on Income Inequality in an Unequal Society: The Case of South Africa	8
Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments	8
The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis	8
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM	7
Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD	7
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”	7
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	7
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	7
EQ-5D-5L Population Norms for Italy	7
Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review	7
Centralised Pharmaceutical Procurement: Learnings from Six European Countries	7
Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results	7
Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review	7
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version	7
The Cost Effectiveness of Taxation of Sugary Foods and Beverages: A Systematic Review of Economic Evaluations	6
Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study	6
Consumers' Preferences and Willingness to Pay for Personalised Nutrition	6
Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions	6
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update	6
Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis	6
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	6

Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	6
Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment	6
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis	6
Effect of Competition on Generic Drug Prices	5
The Inclusion of Comparative Environmental Impact in Health Technology Assessment: Practical Barriers and Unintended Consequences	5
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries	5
Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom	5
Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland	5
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	5
What Policy Approaches Were Effective in Reducing Catastrophic Health Expenditure? A Systematic Review of Studies from Multiple Countries	5
Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?	5
How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran	5
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe	5
Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment	5
Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact	5
Curos™ Disinfection Caps for the Prevention of Infection When Using Needleless Connectors: A NICE Medical Technologies Guidance	5
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15	5
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	5
A Systematic Review of the Association Between Hospital Cost/price and the Quality of Care	5
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women	4
What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment	4
Costs and Cost-Effectiveness of User-Testing of Health Professionals’ Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic	4
Correction to: Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India’s National Publicly Financed Health Insurance Scheme	4
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England	4
Using Eye-Tracking Technology with Older People in Memory Clinics to Investigate the Impact of Mild Cognitive Impairment on Choices for EQ-5D-5L Health States Preferences	4
Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment	4
A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks	4
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	4
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting	4
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	4
Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines	4
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China	4
Evaluating Equity in Health Financing Using Benefit Incidence Analysis: A Framework for Accounting for Quality of Care	4
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	4
Elections have Consequences: Partisan Politics may be Literally Killing Us	4
Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C	4
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers	4
A Review of Web-Based Tools for Value-of-Information Analysis	4
Comment on: “The Italian NHS: What Lessons to Draw from COVID-19?”	4
Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review	4
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis	4
Comment on: “Willingness to Pay for a COVID-19 Vaccine”	4
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia	3
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	3
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	3
Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance	3
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores	3
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	3
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations	3
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease	3
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden	3
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi	3
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	3
Towards a New Understanding of Unmet Medical Need	3
Global Pull Incentives for Better Antibacterials: The UK Leads the Way	3
The Effect of Price Changes and Teaspoon Labelling on Intention to Purchase Sugar-Sweetened Beverages: A Discrete Choice Experiment	3
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries	3
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis	3
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches	3
Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools	3
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	3
Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents	3
Evaluating Health Inequality in Five Caribbean Basin Countries Using EQ-5D-5L	2
Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov	2
The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil	2
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand	2
An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials	2
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies	2
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	2
Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa	2
Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance	2
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	2
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes	2
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children	2
How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG?	2
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	2
Episcissors-60 for Mediolateral Episiotomy: Evaluation of Clinical and Economic Evidence to Inform NICE Medical Technologies Guidance	2
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	2
Availability and Variability of Consumer Prices for Lumbar Discectomy Across US Hospitals in 2018	2
Economic Evaluation of Senshio® (Ospemifene) for the Treatment of Vulvovaginal Atrophy in Scotland	2

Integrated Care in Europe: Time to Get it Together?	2
The Vatican City State Internal Healthcare System Response to COVID-19 Pandemic: Prevention and Control Strategies	2
Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study	2
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	2
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	2
A Systematic Review of Kidney Transplantation Decision Modelling Studies	2
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	2
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	2
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries	2
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic	2
Price Reduction of Anticancer Drugs from 2007 to 2019 in South Korea: The Impact of Pharmaceutical Cost-Containment Policies	2
Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review	2
Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK	2
From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R	2